Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells

Hormone and Metabolic Research

Volumn 29, Issue 8, 1997, Pages 379-382

  Solomon, S S ^a,b   Mishra, S K ^a   Cwik, C ^a   Rajanna, B ^a   Postlethwaite, A E ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Calmodulin; Glucose Utilization; H 411E Cells; Lipogenesis; Non insulin Dependent Diabetes Mellitus (NIDDM)

Indexed keywords

CALMODULIN; INSULIN; MESSENGER RNA; METFORMIN; PIOGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE UTILIZATION; IN VITRO STUDY; INSULIN RESISTANCE; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030739844     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979059     Document Type: Article

References (14)

1. Hotamisligil, G. S., N. S. Shargill, B. M. Spiegelman: Adipose expression of tumor necrosis factorα: Direct role in obesity-linked insulin resistance. Science 289: 87-91 (1993)
2. Lang, CH., C. Dobrescu, G. J. Bagby: Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130: 43-52 (1992)
3. Old, L. J.: Tumor necrosis factor (TNF). Science 230: 630-633 (1985)
4. Hotamisligil, G. S., P. Arner, J. F. Caro, R. L. Atkinson, B. M. Spiegelman: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95: 2409-2415 (1995)
5. Kern, P. A., M. Sagizadeh, J. M. Ong, R. J. Bosch, R. Deem, R. B. Simsolo: The expression of tumor necrosis factor in human adipose tissue. J Clin Invest 95: 2111-2119 (1995)
6. Solomon, S. S., A. E. Kitabchi: Studies of adenosine and dibutyryl adenosine 3′,5′-monophosphoric acid on the isolated fat cell. Diabetes 21: 1027-1034, (1972)
7. Solomon, S. S., M. R. Palazzolo, M. B. Elam, S. A. Green, R. S. Raghow: Regulation of calmodulin gene expression by insulin is both transcriptional and post-transcriptional. J Lab Clin Med 124: 348-358 (1994)
8. Solomon, S. S., M. R. Palazzolo, J. A. Smoake, R. S. Raghow: Insulin-stimulated calmodulin gene expression in rat H-411 E cells can be selectively blocked by antisense oliogonucleotides. Biochem Biophys Res Commun 210 (3): 921-930 (1995)
9. Solomon, S. S., M. R. Palazzolo, S. Green, R. S. Raghow: Expression of calmodulin gene is down-regulated in diabetic BB rats. Biochem Biophys Res Commun 168 (3): 1007-1012 (1990)
10. Solomon, S. S., S. K. Mishra, M. R. Palazzolo, A. E. Postlethwaite, J. M. Seyer: Identification of specific sites in the TNF-α molecule promoting insulin resistance in H-411 E cells. J Lab Clin Med, in press (1996)
11. Solomon, S. S., S. K. Mishra, M. R. Palazzolo, A. E. Postlethwaite, R. S. Raghow: Insulin stimulates and TNF-α inhibits calmodulin gene expression. 9 th International Conference on Second Messengers & Phosphoproteins, in press (1997)
12. Hotmasligil G. S., P. Peraldi, A. Budavari, R. Ellis, M. F. White, B. M. Spiegelman: IRS-1-Mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance. Science 271: 665-668 (1996)
13. Hofmann, C., K. Lorenz, J. Colca: Glucose transport deficiency in diabetic animals is corrected by treatment with the oral anti-hyperglycemic agent, pioglitazone. Endocrinology 129: 1915-1925 (1991)
14. Waugri, A. E.: Elements of Statistical Method. 3rd ed. New York, McGraw-Hill (1952)